CDNA vs NTRA
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 13, 2026
CDNA
NTRA
Investment Advisor Scores
NTRA
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CDNA | NTRA | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 144.9275 | 5000 | CDNA |
| PEG Ratio | -0.12 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 52.2% | 37.7% | CDNA |
| Earnings Growth | 0.0% | 0.0% | Tie |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 36.5/100 | 46.5/100 | NTRA |
| Profit Margin | 24.2% | -7.1% | CDNA |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | SELL | HOLD | NTRA |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CDNA
MarkupPrice above SMA50, rising 50-day trend (29.3% over 20 days), RSI 62
NTRA
MarkupPrice above SMA50, rising 50-day trend (14.0% over 20 days), RSI 60
Fundamentals Snapshot
| Metric | CDNA | NTRA |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 37.8 | -3196.6 |
| Trailing P/E | 24.0 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.5% | 0.4% |
| Gross Margin | 0.7% | 0.7% |
| Operating Margin | 0.0% | -0.1% |
| EPS | 2.08 | -1.34 |
| Dividend Yield | — | — |